Bioavailability and metabolism of dietary flavonoids - much known - much more to discover

Flavonoids: Biosynthesis, Biological Effects and Dietary Sources

Volumn , Issue , 2009, Pages 1-52

  Stevenson, David E ^a   Scheepens, Arjan ^a   Hurst, Roger D ^a  

^a THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882752892     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (275)

1. Heiss, C.; Finis, D.; Kleinbongard, P.; Hoffmann, A.; Rassaf, T.; Kelm, M.; and Sies, H. (2007). Sustained increase in flow-mediated dilation after daily intake of highflavanol cocoa drink over 1 week. Journal of Cardiovascular Pharmacology and Therapeutics, 49, 74-80.
2. Tavani, A.; Spertini, L.; Bosetti, C.; Parpinel, M.; Gnagnarella, P.; Bravi, F.; Peterson, J.; Dwyer, J.; Lagiou, P.; Negri, E.; and La Vecchia, C. (2006). Intake of specific flavonoids and risk of acute myocardial infarction in Italy. Public Health Nutrition, 9, 369-374.
3. Mink, P. J.; Scrafford, C. G.; Barraj, L. M.; Harnack, L.; Hong, C.-P.; Nettleton, J. A.; and Jacobs, D. R., Jr. (2007). Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. American Journal of Clinical Nutrition, 85, 895-909.
4. Naissides, M.; Pal, S.; Mamo, J. C. L.; James, A. P.; and Dhaliwal, S. (2006). The effect of chronic consumption of red wine polyphenols on vascular function in postmenopausal women. European Journal of Clinical Nutrition, 60, 740-745.
5. Bayard, V.; Chamorro, F.; Motta, J.; and Hollenberg, N. K. (2007). Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, stroke, diabetes mellitus, and cancer in Panama. International Journal of Medical Sciences, 4, 53-58.
6. Hodgson, J. M.; Puddey, I. B.; Burke, V.; and Croft, K. D. (2006). Is reversal of endothelial dysfunction by tea related to flavonoid metabolism? British Journal of Nutrition, 95, 14-17.
7. Neuhouser, M. L. (2004). Dietary flavonoids and cancer risk: Evidence from human population studies. Nutrition and Cancer, 50, 1-7.
8. Hertog, M. G. L.; Feskens, E. J. M.; Hollman, P. C. H.; Katan, M. B.; and Kromhout, D. (1994). Dietary flavonoids and cancer risk in the Zutphen Elderly Study. Nutrition and Cancer-an International Journal, 22, 175.
9. Hertog, M. G. L.; Feskens, E. J. M.; Hollman, P. C. H.; Katan, M. B.; and Kromhout, D. (1993). Dietary antioxidant Ffonoids and risk of coronary heart-disease -the Zutphen Elderly Study. Lancet, 342, 1007.
10. Bosetti, C.; Rossi, M.; McLaughlin, J. K.; Negri, E.; Talamini, R.; Lagiou, P.; Montella, M.; Ramazzotti, V.; Franceschi, S.; and LaVecchia, C. (2007). Flavonoids and the risk of renal cell carcinoma. Cancer Epidemiology Biomarkers and Prevention, 16, 98-101.
11. Cui, Y.; Morgenstern, H.; Greenland, S.; Tashkin, D. P.; Mao, J. T.; Cai, L.; Cozen, W.; Mack, T. M.; Lu, Q.-Y.; and Zhang, Z.-F. (2008). Dietary flavonoid intake and lung cancer -A population-based case-control study. Cancer, 112, 2241-2248.
12. Hooper, L.; Kroon, P. A.; Rimm, E. B.; Cohn, J. S.; Harvey, I.; Le Cornu, K. A.; Ryder, J. J.; Hall, W. L.; and Cassidy, A. (2008). Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition, 88, 38-50.
13. Stevenson, D. E.; and Hurst, R. D. (2007). Polyphenolic phytochemicals -just antioxidants or much more? Cellular and Molecular Life Sciences, 64, 2900-2916.
14. Scheline, R. R. (1991). Handbook of mammalian metabolism of plant compounds. Boca Raton: CRC Press.
15. Aura, A.-M. (2008). Microbial metabolism of dietary phenolic compounds in the colon. Phytochemistry Reviews, 7, 407-429.
16. Clifford, M. N. (2004). Diet-derivedPhenols in plasma and tissues and their implications for health. Planta Medica, 70, 1103-1114.
17. Kroon, P.; and Williamson, G. (2005). Polyphenols: dietary components with established benefits to health? Journal of the Science of Food and Agriculture, 85, 1239-1240.
18. Kroon, P. A.; Clifford, M. N.; Crozier, A.; Day, A. J.; Donovan, J. L.; Manach, C.; and Williamson, G. (2004). How should we assess the effects of exposure to dietary polyphenols in vitro? American Journal of Clinical Nutrition, 80, 15-21.
19. Manach, C.; and Donovan, J. L. (2004). Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radical Research, 38, 771-785.
20. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; and Remesy, C. (2005). Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. American Journal of Clinical Nutrition, 81, 230S-242S.
21. Walle, T. (2004). Absorption and metabolism of flavonoids. Free Radical Biology and Medicine, 36, 829-837.
22. Williamson, G. (2002). The use of flavonoid aglycones in in vitro systems to test biological activities: based on bioavailability data, is this a valid approach? Phytochemistry Reviews, V1, 215-222.
23. Williamson, G.; and Manach, C. (2005). Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. American Journal of Clinical Nutrition, 81, 243S-255S.
24. Scalbert, A.; Morand, C.; Manach, C.; and Remesy, C. (2002). Absorption and metabolism of polyphenols in the gut and impact on health. Biomedicine and Pharmacotherapy, 56, 276-282.
25. Karakaya, S. (2004). Bioavailability of phenolic compounds. Critical Reviews in Food Science and Nutrition, 44, 453-464.
26. Clifford, M. N.; and Brown, J. E. (2006). Dietary flavonoids and health -broadening the perspective. In O. M. Andersen; and K. R. Markham (Eds.), Flavonoids: Chemistry, Biochemistry and Applications (pp. 319-370). Boca Raton: CRC Press.
27. Kay, C. D. (2006). Aspects of anthocyanin absorption, metabolism and pharmacokinetics in humans. Nutrition Research Reviews, 19, 137-146.
28. McGhie, T. K.; and Walton, M. C. (2007). The bioavailability and absorption of anthocyanins: Towards a better understanding. Molecular Nutrition and Food Research, 51, 702-713.
29. Zhang, L.; Zuo, Z.; and Lin, G. (2007). Intestinal and hepatic glucuronidation of flavonoids. Molecular Pharmaceutics, 4, 833-845.
30. Larkin, T.; Price, W. E.; and Astheimer, L. (2008). The key importance of soy isoflavone bioavailability to understanding health benefits. Critical Reviews in Food Science and Nutrition, 48, 538-552.
31. Mullie, P.; Clarys, P.; Deriemaeker, P.; and Hebbelinck, M. (2008). Estimation of daily human intake of food flavonoids. International Journal of Food Sciences and Nutrition, 59, 291-298.
32. Walle, T.; Browning, A. M.; Steed, L. L.; Reed, S. G.; and Walle, U. K. (2005). Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. Journal of Nutrition, 135, 48-52.
33. Crespy, V.; Morand, C.; Besson, C.; Manach, C.; Demigne, C.; and Remesy, C. (2002). Quercetin, but not its glycosides, is absorbed from the rat stomach. Journal of Agricultural and Food Chemistry, 50, 618-621.
34. Spencer, J. P. E.; Chaudry, F.; Pannala, A. S.; Srai, S. K.; Debnam, E.; and Rice-Evans, C. (2000). Decomposition of cocoa procyanidins in the gastric milieu. Biochemical and Biophysical Research Communications, 272, 236-241.
35. Rios, L. Y.; Bennett, R. N.; Lazarus, S. A.; Remesy, C.; Scalbert, A.; and Williamson, G. (2002). Cocoa procyanidins are stable during gastric transit in humans'. American Journal of Clinical Nutrition, 76, 1106-1110.
36. Talavera, S.; Felgines, C.; Texier, O.; Besson, C.; Lamaison, J. L.; and Remesy, C. (2003). Anthocyanins are efficiently absorbed from the stomach in anesthetized rats. Journal of Nutrition, 133, 4178-4182.
37. McDougall, G. J.; Dobson, P.; Smith, P.; Blake, A.; and Stewart, D. (2005). Assessing potential bioavailability of raspberry anthocyanins using an in vitro digestion system. Journal of Agricultural and Food Chemistry, 53, 5896-5904.
38. Walton, M. C.; Hendriks, W. H.; Broomfield, A. M.; and McGhie, T. (2009). A viscous food matrix influences absorption and excretion but not metabolism of blackcurrant anthocyanins in rats. Journal of Food Science, 74, H22-H29.
39. Walton, M. C.; Lentle, R. G.; Reynolds, G. W.; Kruger, M. C.; and McGhie, T. K. (2006). Anthocyanin absorption and antioxidant status in pigs. Journal of Agricultural and Food Chemistry, 54, 7940-7946.
40. Sergent, T.; Ribonnet, L.; Kolosova, A.; Garsou, S.; Schaut, A.; De Saeger, S.; Van Peteghem, C.; Larondelle, Y.; Pussemier, L.; and Schneider, Y. J. (2008). Molecular and cellular effects of food contaminants and secondary plant components and their plausible interactions at the intestinal level. Food and Chemical Toxicology, 46, 813-841.
41. Shah, P.; Jogani, V.; Bagchi, T.; and Misra, A. (2006). Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotechnology Progress, 22, 186-198.
42. Hu, M.; Chen, J.; and Lin, H. M. (2003). Metabolism of flavonoids via enteric recycling: Mechanistic studies of disposition of apigenin in the Caco-2 cell culture model. Journal of Pharmacology and Experimental Therapeutics, 307, 314-321.
43. Bieger, J.; Cermak, R.; Blank, R.; de Boer, V. C. J.; Hollman, P. C. H.; Kamphues, J.; and Wolffram, S. (2008). Tissue distribution of quercetin in pigs after long-term dietary supplementation. Journal of Nutrition, 138, 1417-1420.
44. de Boer, V. C. J.; Dihal, A. A.; van der Woude, H.; Arts, I. C. W.; Wolffram, S.; Alink, G. M.; Rietjens, I. M. C. M.; Keijer, J.; and Hollman, P. C. H. (2005). Tissue distribution of quercetin in rats and pigs. Journal of Nutrition, 135, 1718-1725.
45. Wiczkowski, W.; Romaszko, J.; Bucinski, A.; Szawara-Nowak, D.; Honke, J.; Zielinski, H.; and Piskula, M. K. (2008). Quercetin from shallots (Allium cepa L. var. aggregatum) is more bioavailable than its glucosides. Journal of Nutrition, 138, 885-888.
46. Nemeth, K.; Plumb, G. W.; Berrin, J.-G.; Juge, N.; Jacob, R.; Naim, H. Y.; Williamson, G.; Swallow, D. M.; and Kroon, P. A. (2003). Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. European Journal of Nutrition, 42, 29-42.
47. Day, A. J.; Canada, F. J.; Diaz, J. C.; Kroon, P. A.; McLauchlan, R.; Faulds, C. B.; Plumb, G. W.; Morgan, M. R. A.; and Williamson, G. (2000). Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Letters, 468, 166-170.
48. Day, A. J.; DuPont, M. S.; Ridley, S.; Rhodes, M.; Rhodes, M. J. C.; Morgan, M. R. A.; and Williamson, G. (1998). Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Letters, 436, 71-75.
49. Gee, J. M.; DuPont, M. S.; Day, A. J.; Plumb, G. W.; Williamson, G.; and Johnson, I. T. (2000). Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. Journal of Nutrition, 130, 2765-2771.
50. Arts, I. C. W.; Sesink, A. L. A.; Faassen-Peters, M.; and Hollman, P. C. H. (2004). The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides. British Journal of Nutrition, 91, 841-847.
51. Spencer, J. P. E.; Chowrimootoo, G.; Choudhury, R.; Debnam, E. S.; Srai, S. K.; and Rice-Evans, C. (1999). The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Letters, 458, 224-230.
52. Serra, H.; Mendes, T.; Bronze, M. R.; and Simplicio, A.L. (2008). Prediction of intestinal absorption and metabolism of pharmacologically active flavones and flavanones. Bioorganic and Medicinal Chemistry, 16, 4009-4018.
53. Brand, W.; van der Wel, P. A. I.; Rein, M. J.; Barron, D.; Williamson, G.; van Bladeren, P. J.; and Rietjens, I. (2008). Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers. Drug Metabolism and Disposition, 36, 1794-1802.
54. Kobayashi, S.; and Konishi, Y. (2008). Transepithelial transport of flavanone in intestinal Caco-2 cell monolayers. Biochemical and Biophysical Research Communications, 368, 23-29.
55. Kobayashi, S.; Tanabe, S.; Sugiyama, M.; and Konishi, Y. (2008). Transepithelial transport of hesperetin and hesperidin in intestinal Caco-2 cell monolayers. Biochimica et Biophysica Acta-Biomembranes, 1778, 33-41.
56. Hollman, P. C. H.; Van Trijp, J. M. P.; Buysman, M. N. C. P.; V.d. Gaag, M. S.; Mengelers, M. J. B.; De Vries, J. H. M.; and Katan, M. B. (1997). Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Letters, 418, 152-156.
57. Zhang, L.; Lin, G.; Chang, Q.; and Zuo, Z. (2005). Role of intestinal first-pass metabolism of baicalein in its absorption process. Pharmaceutical Research, 22, 10501058.
58. Silberberg, M.; Morand, C.; Mathevon, T.; Besson, C.; Manach, C.; Scalbert, A.; and Remesy, C. (2005). The bioavailability of polyphenols is highly governed by the capacity of the intestine and of the liver to secrete conjugated metabolites. European Journal of Nutrition, 45, 88-96.
59. Crespy, V.; Morand, C.; Manach, C.; Besson, C.; Demigne, C.; and Remesy, C. (1999). Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. American Journal of Physiology-Gastrointestinal and Liver Physiology, 277, G120-G126.
60. Kahle, K.; Huemmer, W.; Kempf, M.; Scheppach, W.; Erk, T.; and Richling, E. (2007). Polyphenols are intensively metabolized in the human gastrointestinal tract after apple juice consumption. Journal of Agricultural and Food Chemistry, 55, 10605-10614.
61. Cao, J.; Chen, X.; Liang, J.; Yu, X. Q.; Xu, A. L.; Chan, E.; Duan, W.; Huang, M.; Wen, J. Y.; Yu, X. Y.; Li, X. T.; Sheu, F. S.; and Zhou, S. F. (2007). Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra. Drug Metabolism and Disposition, 35, 539-553.
62. Xu, Y. A.; Fan, G. R.; Gao, S.; and Hong, Z. Y. (2008). Assessment of intestinal absorption of vitexin-2"-O-rhamnoside in hawthorn leaves flavonoids in rat using in situ and in vitro absorption models. Drug Development and Industrial Pharmacy, 34, 164-170.
63. Williamson, G.; Aeberli, I.; Miguet, L.; Zhang, Z.; Sanchez, M. B.; Crespy, V.; Barron, D.; Needs, P.; Kroon, P. A.; Glavinas, H.; Krajcsi, P.; and Grigorov, M. (2007). Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2). Drug Metabolism and Disposition, 35, 1262-1268.
64. Murakami, A.; Ohigashi, H.; Koshimizu, K.; Kawahara, S.; Matsuoka, Y.; Kuwahara, S.; Kuki, W.; Takahashi, Y.; and Hosotani, K. (2002). Characteristic rat tissue accumulation of nobiletin, a chemopreventive polymethoxyflavonoid, in comparison with luteolin. BioFactors, 16, 73-82.
65. Walle, T. (2007). Methylation of dietary flavones greatly improves their hepatic metabolic stability and intestinal absorption. Molecular Pharmaceutics, 4, 826-832.
66. Walle, T. (2007). Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? Seminars in Cancer Biology, 17, 354-362.
67. Walle, T.; Wen, X.; and Walle, U. K. (2007). Improving metabolic stability of cancer chemoprotective polyphenols. Expert Opinion on Drug Metabolism and Toxicology, 3, 379-388.
68. Walle, U. K.; and Walle, T. (2007). Bioavailable flavonoids: Cytochrome P450mediated metabolism of methoxyflavones. Drug Metabolism and Disposition, 35, 1985-1989.
69. O'Leary, K. A.; Day, A. J.; Needs, P. W.; Mellon, F. A.; O'Brien, N. M.; and Williamson, G. (2003). Metabolism of quercetin-7-and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochemical Pharmacology, 65, 479-491.
70. Graf, B. A.; Ameho, C.; Dolnikowski, G. G.; Milbury, P. E.; Chen, C.-Y.; and Blumberg, J. B. (2006). Rat gastrointestinal tissues metabolize quercetin. Journal of Nutrition, 136, 39-44.
71. Hollands, W.; Brett, G. M.; Radreau, P.; Saha, S.; Teucher, B.; Bennett, R. N.; and Kroon, P. A. (2008). Processing blackcurrants dramatically reduces the content and does not enhance the urinary yield of anthocyanins in human subjects. Food Chemistry, 108, 869-878.
72. Prior, R. L.; and Wu, X. L. (2006). Anthocyanins: Structural characteristics that result in unique metabolic patterns and biological activities. Free Radical Research, 40, 1014-1028.
73. El Mohsen, M. A.; Marks, J.; Kuhnle, G.; Moore, K.; Debnam, E.; Srai, S. K.; Rice-Evans, C.; and Spencer, J. P. E. (2006). Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats. British Journal of Nutrition, 95.
74. Felgines, C.; Talavera, S.; Texier, O.; Besson, C.; Fogliano, V.; Lamaison, J.-L.; Fauci, L. L.; Galvano, G.; Remesy, C.; and Galvano, F. (2006). Absorption and metabolism of red orange juice anthocyanins in rats. British Journal of Nutrition, 95, 898-904.
75. Matuschek, M. C.; Hendriks, W. H.; McGhie, T. K.; and Reynolds, G. W. (2006). The jejunum is the main site of absorption for anthocyanins in mice. Journal of Nutritional Biochemistry, 17, 31-36.
76. Harada, K.; Kano, M.; Takayanagi, T.; Yamakawa, O.; and Ishikawa, F. (2004). Absorption of acylated anthocyanins in rats and humans after ingesting an extract of Ipomoea batatas purple sweet potato tuber. Bioscience Biotechnology and Biochemistry, 68, 1500-1507.
77. Talavéra, S.; Felgines, C.; Texier, O.; Lamaison, J.-L.; Besson, C.; Gil-Izquierdo, A.; and Rémesy, C. (2005). Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain. Journal of Agricultural and Food Chemistry, 53, 3902-3908.
78. Passamonti, S.; Vrhovsek, U.; Vanzo, A.; and Mattivi, F. (2005). Fast access of some grape pigments to the brain. Journal of Agricultural and Food Chemistry, 53, 70297034.
79. Chen, T.; Li, L. P.; Lu, X. Y.; Jiang, H. D.; and Zeng, S. (2007). Absorption and excretion of luteolin and apigenin in rats after oral administration of Chrysanthemum morifolium extract. Journal of Agricultural and Food Chemistry, 55, 273-277.
80. Kahle, K.; Kraus, M.; Scheppach, W.; Ackermann, M.; Ridder, F.; and Richling, E. (2006). Studies on apple and blueberry fruit constituents: Do the polyphenols reach the colon after ingestion? Molecular Nutrition and Food Research, 50, 418-423.
81. Akao, T.; Kawabata, K.; Yanagisawa, E.; Ishihara, K.; Mizuhara, Y.; Wakui, Y.; Sakashita, Y.; and Kobashi, K. (2000). Balicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. Journal of Pharmacy and Pharmacology, 52, 1563.
82. Ichiyanagi, T.; Shida, Y.; Rahman, M. M.; Hatano, Y.; and Konishi, T. (2006). Bioavailability and Tissue Distribution of Anthocyanins in Bilberry (Vaccinium myrtillus L.) Extract in Rats. Journal of Agricultural and Food Chemistry, 54, 65786587.
83. Kalt, W.; Blumberg, J. B.; McDonald, J. E.; Vinqvist-Tymchuk, M. R.; Fillmore, S. A. E.; Graf, B. A.; O'Leary, J. M.; and Milbury, P. E. (2008). Identification of anthocyanins in the liver, eye, and brain of blueberry-fed pigs. Journal of Agricultural and Food Chemistry, 56, 705-712.
84. Andres-Lacueva, C.; Shukitt-Hale, B.; Galli, R. L.; Jauregui, O.; Lamuela-Raventos, R. M.; and Joseph, J. A. (2005). Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutritional Neuroscience, 8, 111-120.
85. Xia, H. J.; Qiu, F.; Zhu, S.; Zhang, T. Y.; Qu, G. X.; and Yao, X. S. (2007). Isolation and identification of ten metabolites of breviscapine in rat urine. Biological and Pharmaceutical Bulletin, 30, 1308-1316.
86. Kuhnle, G.; Spencer, J. P. E.; Schroeter, H.; Shenoy, B.; Debnam, E. S.; Srai, S. K. S.; Rice-Evans, C.; and Hahn, U. (2000). Epicatechin and catechin are O-methylated and glucuronidated in the small intestine. Biochemical and Biophysical Research Communications, 277, 507-512.
87. Yang, C. S.; Chen, L. S.; Lee, M. J.; Balentine, D.; Kuo, M. C.; and Schantz, S. P. (1998). Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiology Biomarkers and Prevention, 7, 351-354.
88. Chu, K. O.; Wang, C. C.; Chu, C. Y.; Choy, K. W.; Pang, C. P.; and Rogers, M. S. (2006). Uptake and distribution of catechins in fetal organs following in utero exposure in rats. Human Reproduction, 22, 280-287.
89. Walton, M. C.; McGhie, T. K.; Reynolds, G. W.; and Hendriks, W. H. (2006). The flavonol quercetin-3-glucoside inhibits cyanidin-3-glucoside absorption in vitro. Journal of Agricultural and Food Chemistry, 54, 4913-4920.
90. Suganuma, M.; Okabe, S.; Oniyama, M.; Tada, Y.; Ito, H.; and Fujiki, H. (1998). Wide distribution of H-3 (-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis, 19, 1771-1776.
91. Kay, C. D.; Mazza, G.; Holub, B. J.; and Wang, J. (2004). Anthocyanin metabolites in human urine and serum. British Journal of Nutrition, 91, 933-942.
92. Tsuda, T.; Horio, F.; and Osawa, T. (1999). Absorption and metabolism of cyanidin 3O-[beta]-glucoside in rats. FEBS Letters, 449, 179-182.
93. Ruefer, C. E.; Bub, A.; Moeseneder, J.; Winterhalter, P.; Stuertz, M.; and Kulling, S. E. (2008). Pharmacokinetics of the soybean isoflavone daidzein in its aglycone and glucoside form: a randomized, double-blind, crossover study. American Journal of Clinical Nutrition, 87, 1314-1323.
94. Ichiyanagi, T.; Rahman, M. M.; Kashiwada, Y.; Ikeshiro, Y.; Shida, Y.; Hatano, Y.; Matsumoto, H.; Hirayama, M.; Tsuda, T.; and Konishi, T. (2004). Absorption and metabolism of delphinidin 3-O-[beta]-glucopyranoside in rats. Free Radical Biology and Medicine, 36, 930-937.
95. Poquet, L.; Clifford, M. N.; and Williamson, G. (2008). Investigation of the metabolic fate of dihydrocaffeic acid. Biochemical Pharmacology, 75, 1218-1229.
96. Cao, G.; Muccitelli, H. U.; Sanchez-Moreno, C.; and Prior, R. L. (2001). Anthocyanins are absorbed in glycated forms in elderly women: a pharmacokinetic study. American Journal of Clinical Nutrition, 73, 920-926.
97. Ito, C.; Oi, N.; Hashimoto, T.; Nakabayashi, H.; Aoki, F.; Tominaga, Y.; Yokota, S.; Hosoe, K.; and Kanazawa, K. (2007). Absorption of dietary licorice isoflavan glabridin to blood circulation in rats. Journal of Nutritional Science and Vitaminology, 53, 358-365.
98. Mata-Bilbao, M. D.; Andres-Lacueva, C.; Roura, E.; Jaduregui, O.; Escriban, E.; Torre, C.; and Lamuela-Raventos, R. M. (2007). Absorption and pharmacokinetics of grapefruit flavanones in beagles. British Journal of Nutrition, 98, 86-92.
99. Kanaze, F. I.; Bounartzi, M. I.; Georgarakis, M.; and Niopas, I. (2007). Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. European Journal of Clinical Nutrition, 61, 472-477.
100. Franke, A. A.; Custer, L. J.; and Hundahl, S. A. (2004). Determinants for urinary and plasma isoflavones in humans after soy intake. Nutrition and Cancer, 50, 141-154.
101. DuPont, M. S.; Day, A. J.; Bennett, R. N.; Mellon, F. A.; and Kroon, P. A. (2004). Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans. European Journal of Clinical Nutrition, 58, 947.
102. Choudhury, R.; Chowrimootoo, G.; Srai, K.; Debnam, E.; and Rice-Evans, C. A. (1999). Interactions of the flavonoid naringenin in the gastrointestinal tract and the influence of glycosylation. Biochemical and Biophysical Research Communications, 265, 410-415.
103. Gardana, C.; Guarnieri, S.; Riso, P.; Simonetti, P.; and Porrini, M. (2007). Flavanone plasma pharmacokinetics from blood orange juice in human subjects. British Journal of Nutrition, 98, 165-172.
104. Mennen, L. I.; Sapinho, D.; Ito, H.; Galan, P.; Hercberg, S.; and Scalbert, A. (2008). Urinary excretion of 13 dietary flavonoids and phenolic acids in free-living healthy subjects variability and possible use as biomarkers of polyphenol intake. European Journal of Clinical Nutrition, 62, 519-525.
105. Crespy, V.; Morand, C.; Besson, C.; Manach, C.; Demigne, C.; and Remesy, C. (2001). Comparison of the intestinal absorption of quercetin, phloretin and their glucosides in rats. Journal of Nutrition, 131, 2109-2114.
106. Zhou, D. Y.; Xing, R.; Xu, Q.; Xue, X. Y.; Zhang, F. F.; and Liang, X. M. (2008). Polymethoxylated flavones metabolites in rat plasma after the consumption of Fructus aurantii extract: Analysis by liquid chromatography/electrospray ion trap mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 46, 543-549.
107. Spencer, J. P. E.; Schroeter, H.; Shenoy, B.; Srai, S. K. S.; Debnam, E. S.; and Rice-Evans, C. (2001). Epicatechin is the primary bioavailable form of the procyanidin dimers B2 and B5 after transfer across the small intestine. Biochemical and Biophysical Research Communications, 285, 588-593.
108. Wang, J. F.; Schramm, D. D.; Holt, R. R.; Ensunsa, J. L.; Fraga, C. G.; Schmitz, H. H.; and Keen, C. L. (2000). A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. Journal of Nutrition, 130, 2115S-2119S.
109. Donovan, J. L.; Manach, C.; Rios, L.; Morand, C.; Scalbert, A.; and Remesy, C. (2002). Procyanidins are not bioavailable in rats fed a single meal containing a grapeseed extract or the procyanidin dimer B-3. British Journal of Nutrition, 87, 299-306.
110. Nakamura, Y.; and Tonogai, Y. (2003). Metabolism of grape seed polyphenol in the rat. Journal of Agricultural and Food Chemistry, 51, 7215-7225.
111. Prasain, J. K.; Jones, K.; Brissie, N.; Moore, R.; Wyss, J. M.; and Barnes, S. (2004). Identification of Puerarin and Its Metabolites in Rats by Liquid Chromatography-Tandem Mass Spectrometry. Journal of Agricultural and Food Chemistry, 52, 37083712.
112. Murota, K.; and Terao, J. (2005). Quercetin appears in the lymph of unanesthetized rats as its phase II metabolites after administered into the stomach. FEBS Letters, 579, 5343-5346.
113. Day, A. J.; Mellon, F.; Barron, D.; Sarrazin, G.; Morgan, M. R. A.; and Williamson, G. (2001). Human metabolism of dietary flavonoids: Identification of plasma metabolites of quercetin. Free Radical Research, 35, 941-952.
114. Graefe, E. U.; Wittig, J.; Mueller, S.; Riethling, A. K.; Uehleke, B.; Drewelow, B.; Pforte, H.; Jacobasch, G.; Derendorf, H.; and Veit, M. (2001). Pharmacokinetics and bioavailability of quercetin glycosides in humans. Journal of Clinical Pharmacology, 41, 492-499.
115. Wittig, J.; Herderich, M.; Graefe, E. U.; and Veit, M. (2001). Identification of quercetin glucuronides in human plasma by high-performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, 753, 237-243.
116. Mullen, W.; Edwards, C. A.; and Crozier, A. (2006). Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl-and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. British Journal of Nutrition, 96, 107-116.
117. Benito, S.; Mitjavila, M. T.; and Buxaderas, S. (2004). Flavonoid metabolites and susceptibility of rat lipoproteins to oxidation. American Journal of Physiology -Heart and Circulatory Physiology, 287.
118. Day, A. J.; Gee, J. M.; DuPont, M. S.; Johnson, I. T.; and Williamson, G. (2003). Absorption of quercetin-3-glucoside and quercetin-4 '-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochemical Pharmacology, 65, 1199-1206.
119. Moon, Y.J.; Wang, L.; DiCenzo, R.; and Morris, M. E. (2008). Quercetin pharmacokinetics in humans. Biopharmaceutics and Drug Disposition, 29, 205-217.
120. Dragoni, S.; Gee, J.; Bennett, R.; Valoti, M.; and Sgaragli, G. (2006). Red wine alcohol promotes quercetin absorption and directs its metabolism towards isorhamnetin and tamarixetin in rat intestine in vitro. British Journal of Pharmacology, 147, 765-771.
121. Kuhnle, G.; Spencer, J. P. E.; Chowrimootoo, G.; Schroeter, H.; Debnam, E. S.; Srai, S. K. S.; Rice-Evans, C.; and Hahn, U. (2000). Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochemical and Biophysical Research Communications, 272, 212-217.
122. Goldberg, D. A.; Yan, J.; and Soleas, G. J. (2003). Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clinical Biochemistry, 36, 79-87.
123. Vitrac, X.; Desmouliere, A.; Brouillaud, B.; Krisa, S.; Deffieux, G.; Barthe, N.; Rosenbaum, J.; and Merillon, J. M. (2003). Distribution of C-14 -trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sciences, 72, 2219-2233.
124. Chen, X. Y.; Cui, L.; Duan, X. T.; Ma, B.; and Zhong, D. F. (2006). Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration. Drug Metabolism and Disposition, 34, 1345.
125. Gee, J. M.; Wroblewska, M. A.; Bennett, R. N.; Mellon, F. A.; and Johnson, I. T. (2004). Absorption and twenty-four-hour metabolism time-course of quercetin-3-Oglucoside in rats, in vivo. Journal of the Science of Food and Agriculture, 84, 1341-1348.
126. Tsuji, A.; Takanaga, H.; Tamai, I.; and Terasaki, T. (1994). Transcellular Transport of Benzoic Acid Across Caco-2 Cells by a pH-Dependent and Carrier-Mediated Transport Mechanism. Pharmaceutical Research, 11, 30-37.
127. Tamai, I.; Takanaga, H.; Maeda, H.; Yabuuchi, H.; Sai, Y.; Suzuki, Y.; and Tsuji, A. (1997). Intestinal brush-border membrane transport of monocarboxylic acids mediated by proton-coupled transport and anion antiport mechanisms. Journal of Pharmacy and Pharmacology, 49, 108-112.
128. Konishi, Y.; Kobayashi, S.; and Shimizu, M. (2003). Transepithelial transport of pcoumaric acid and gallic acid in caco-2 cell monolayers. Bioscience Biotechnology and Biochemistry, 67, 2317-2324.
129. Haughton, E.; Clifford, M. N.; and Sharp, P. (2007). Monocarboxylate transporter expression is associated with the absorption of benzoic acid in human intestinal epithelial cells. Journal of the Science of Food and Agriculture, 87, 239-244.
130. Steinert, R. E.; Ditscheid, B.; Netzel, M.; and Jahreis, G. (2008). Absorption of black currant anthocyanins by monolayers of human intestinal epithelial Caco-2 cells mounted in using type chambers. Journal of Agricultural and Food Chemistry, 56, 4995-5001.
131. Jodoin, J.; Demeule, M.; and Beliveau, R. (2002). Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochimica et Biophysica Acta-Molecular Cell Research, 1542, 149-159.
132. Konishi, Y.; Kobayashi, S.; and Shimizu, M. (2003). Tea polyphenols inhibit the transport of dietary phenolic acids mediated by the monocarboxylic acid transporter (MCT) in intestinal Caco-2 cell monolayers. Journal of Agricultural and Food Chemistry, 51, 7296-7302.
133. Konishi, Y.; Kubo, K.; and Shimizu, M. (2003). Structural effects of phenolic acids on the transepithelial transport of fluorescein in Caco-2 cell monolayers. Bioscience Biotechnology and Biochemistry, 67, 2014-2017.
134. Hong, S. S.; Seo, K.; Lim, S. C.; and Han, H. K. (2007). Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3). Pharmacological Research, 56, 468-473.
135. Wen, X.; and Walle, T. (2006). Methylation protects dietary flavonoids from rapid hepatic metabolism. Xenobiotica, 36, 387-397.
136. Wen, X.; and Walle, T. (2006). Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metabolism and Disposition, 34, 1786-1792.
137. Liu, X.; Tam, V. H.; and Hu, M. (2007). Disposition of flavonoids via enteric recycling: Determination of the UDP-Glucuronosyltransferase Isoforms responsible for the metabolism of flavonoids in intact caco-2 TC7 cells using siRNA. Molecular Pharmaceutics, 4, 873-882.
138. Manna, C.; Galletti, P.; Maisto, G.; Cucciolla, V.; D'Angelo, S.; and Zappia, V. (2000). Transport mechanism and metabolism of olive oil hydroxytyrosol in Caco-2 cells. FEBS Letters, 470, 341-344.
139. Murakami, A.; Koshimizu, K.; Kuwahara, S.; Takahashi, Y.; Ito, C.; Furukawa, H.; Ju-Ichi, M.; and Ohigashi, H. (2001). In vitro absorption and metabolism of nobiletin, a chemopreventive polymethoxyflavonoid in citrus fruits. Bioscience, Biotechnology and Biochemistry, 65, 194-197.
140. Boyer, J.; Brown, D.; and Rui, H.L. (2004). Uptake of quercetin and quercetin 3glucoside from whole onion and apple peel extracts by Caco-2 cell monolayers. Journal of Agricultural and Food Chemistry, 52, 7172-7179.
141. Walgren, R. A.; Lin, J.-T.; Kinne, R. K. H.; and Walle, T. (2000). Cellular uptake of dietary flavonoid quercetin 4'-beta -glucoside by sodium-dependent glucose transporter SGLT1. Journal of Pharmacology and Experimental Therapeutics, 294, 837-843.
142. Chen, C. H.; Hsu, H. J.; Huang, Y. J.; and Lin, C. J. (2007). Interaction of flavonoids and intestinal facilitated glucose transporters. Planta Medica, 73, 348-354.
143. Keppler, K.; Hein, E. M.; and Humpf, H. U. (2006). Metabolism of quercetin and rutin by the pig caecal microflora prepared by freeze-preservation. Molecular Nutrition and Food Research, 50, 686-695.
144. Jenner, A. M.; Rafter, J.; and Halliwell, B. (2005). Human fecal water content of phenolics: The extent of colonic exposure to aromatic compounds. Free Radical Biology and Medicine, 38, 763-772.
145. Rechner, A. R.; Kuhnle, G.; Bremner, P.; Hubbard, G. P.; Moore, K. P.; and Rice-Evans, C. A. (2002). The metabolic fate of dietary polyphenols in humans. Free Radical Biology and Medicine, 33, 220-235.
146. Clifford, M. N.; Copeland, E. L.; Bloxsidge, J. P.; and Mitchell, L. A. (2000). Hippuric acid as a major excretion product associated with black tea consumption. Xenobiotica, 30, 317-326.
147. Mulder, T. P.; Rietveld, A. G.; and van Amelsvoort, J. M. (2005). Consumption of both black tea and green tea results in an increase in the excretion of hippuric acid into urine. American Journal of Clinical Nutrition, 81, 256S-260S.
148. Rios, L. Y.; Gonthier, M. P.; Remesy, C.; Mila, L.; Lapierre, C.; Lazarus, S. A.; Williamson, G.; and Scalbert, A. (2003). Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects. American Journal of Clinical Nutrition, 77, 912-918.
149. Hong, Y. J.; and Mitchell, A. E. (2006). Identification of glutathione-related quercetin metabolites in humans. Chemical Research in Toxicology, 19, 1525-1532.
150. Russell, W. R.; Labat, A.; Scobbie, L.; and Duncan, S. H. (2007). Availability of blueberry phenolics for microbial metabolism in the colon and the potential inflammatory implications. Molecular Nutrition and Food Research, 51, 726-731.
151. Gonthier, M. P.; Remesy, C.; Scalbert, A.; Cheynier, V.; Souquet, J. M.; Poutanen, K.; and Aura, A. M. (2006). Microbial metabolism of caffeic acid and its esters chlorogenic and caftaric acids by human faecal microbiota in vitro. Biomedicine and Pharmacotherapy, 60, 536-540.
152. Gonthier, M.-P.; Verny, M.-A.; Besson, C.; Remesy, C.; and Scalbert, A. (2003). Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. Journal of Nutrition, 133, 1853-1859.
153. Andreasen, M. F.; Kroon, P. A.; Williamson, G.; and Garcia-Conesa, M. T. (2001). Intestinal release and uptake of phenolic antioxidant diferulic acids. Free Radical Biology and Medicine, 31, 304-314.
154. Vitaglione, P.; Donnarumma, G.; Napolitano, A.; Galvano, F.; Gallo, A.; Scalfi, L.; and Fogliano, V. (2007). Protocatechuic acid is the major human metabolite of cyanidin-glucosides. Journal of Nutrition, 137, 2043-2048.
155. Kelebek, H.; Canbas, A.; and Selli, S. (2008). Determination of phenolic composition and antioxidant capacity of blood orange juices obtained from cvs. Moro and Sanguinello (Citrus sinensis (L.) Osbeck) grown in Turkey. Food Chemistry, 107, 1710-1716.
156. Nardini, M.; Natella, F.; Scaccini, C.; and Ghiselli, A. (2006). Phenolic acids from beer are absorbed and extensively metabolized in humans. Journal of Nutritional Biochemistry, 17, 14-22.
157. Konishi, Y.; Hitomi, Y.; and Yoshioka, E. (2004). Intestinal absorption of p-coumaric and gallic acids in rats after oral administration. Journal of Agricultural and Food Chemistry, 52, 2527-2532.
158. DuPont, M. S.; Bennett, R. N.; Mellon, F. A.; and Williamson, G. (2002). Polyphenols from alcoholic apple cider are absorbed, metabolized and excreted by humans. Journal of Nutrition, 132, 172-175.
159. Crespy, V.; Aprikian, O.; Morand, C.; Besson, C.; Manach, C.; Demigne, C.; and Remesy, C. (2001). Bioavailability of phloretin and phloridzin in rats. Journal of Nutrition, 131, 3227-3230.
160. He, J.; Magnuson, B. A.; and Giusti, M. M. (2005). Analysis of Anthocyanins in Rat Intestinal Contents-Impact of Anthocyanin Chemical Structure on Fecal Excretion. Journal of Agricultural and Food Chemistry, 53, 2859-2866.
161. Joannou, G. E.; Kelly, G. E.; Reeder, A. Y.; Waring, M.; and Nelson, C. (1995). A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. The Journal of Steroid Biochemistry and Molecular Biology, 54, 167-184.
162. Yuan, J. P.; Wang, J. H.; and Liu, X. (2007). Metabolism of dietary soy isoflavones to equol by human intestinal microflora -implications for health. Molecular Nutrition and Food Research, 51, 765-781.
163. Hoey, L.; Rowland, I. R.; Lloyd, A.S.; Clarke, D. B.; and Wiseman, H. (2004). Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children. British Journal of Nutrition, 91, 607-616.
164. Lee, H. C.; Jenner, A. M.; Low, C. S.; and Lee, Y. K. (2006). Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Research in Microbiology, 157, 876-884.
165. Fleschhut, J.; Kratzer, F.; Rechkemmer, G.; and Kulling, S. E. (2006). Stability and biotransformation of various dietary anthocyanins in vitro. European Journal of Nutrition, 45, 7-18.
166. Hor-Gil Hur, F. R. (2000). Biotransformation of the isoflavonoids biochanin A, formononetin, and glycitein by Eubacterium limosum. FEMS Microbiology Letters, 192, 21-25.
167. Aura, A.-M.; Mattila, I.; Seppänen-Laakso, T.; Miettinen, J.; Oksman-Caldentey, K.M.; and Oresic, M. (2008). Microbial metabolism of catechin stereoisomers by human faecal microbiota: Comparison of targeted analysis and a non-targeted metabolomics method. Phytochemistry Letters, 1, 18-22.
168. Meselhy, M. R.; Nakamura, N.; and Hattori, M. (1997). Biotransformation of (-)epicatechin 3-O-gallate by human intestinal bacteria. Chemical and Pharmaceutical Bulletin, 45, 888-893.
169. Wang, L.-Q.; Meselhy, M.R.; Li, Y.; Nakamura, N.; Min, B.-S.; Qin, G.-W.; and Hattori, M. (2001). The Heterocyclic Ring Fission and Dehydroxylation of Catechins and Related Compounds by Eubacterium sp. Strain SDG-2, a Human Intestinal Bacterium. Chemical and Pharmaceutical Bulletin, 49, 1640-1643.
170. Rafii, F.; Jackson, L. D.; Ross, I.; Heinze, T. M.; Lewis, S. M.; Aidoo, A.; Lyn-Cook, L.; and Manjanathas, M. (2007). Metabolism of daidzein by fecal bacteria in rats. Comparative Medicine, 57, 282-286.
171. Labib, S.; Erb, A.; Kraus, M.; Wickert, T.; and Richling, E. (2004). The pig caecum model: A suitable tool to study the intestinal metabolism of flavonoids. Molecular Nutrition and Food Research, 48, 326-332.
172. Gao, K.; Xu, A. L.; Krul, C.; Venema, K.; Liu, Y.; Niu, Y. T.; Lu, J. X.; Bensoussan, L.; Seeram, N. P.; Heber, D.; and Henning, S. M. (2006). Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3,4-dihydroxyphenylacetic acid has antiproliferative activity. Journal of Nutrition, 136, 52-57.
173. Matthies, A.; Clavel, T.; Gutschow, M.; Engst, W.; Haller, D.; Blaut, M.; and Braune, A. (2008). Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Applied and Environmental Microbiology, 74, 48474852.
174. Schoefer, L.; Mohan, R.; Braune, A.; Birringer, M.; and Blaut, M. (2002). Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiology Letters, 208, 197-202.
175. Deprez, S.; Brezillon, C.; Rabot, S.; Philippe, C.; Mila, I.; Lapierre, C.; and Scalbert, A. (2000). Polymeric Proanthocyanidins Are Catabolized by Human Colonic Microflora into Low-Molecular-Weight Phenolic Acids. Journal of Nutrition, 130, 2733-2738.
176. Schneider, H.; Schwiertz, A.; Collins, M. D.;and Blaut, M. (1999). Anaerobic transformation of quercetin-3-glucoside by bacteria from the human intestinal tract. Archives of Microbiology, 171, 81-91.
177. Aura, A. M.; O'Leary, K. A.; Williamson, G.; Ojala, M.; Bailey, M.; Puupponen-Pimia, R.; Nuutila, A. M.; Oksman-Caldentey, K. M.; and Poutanen, K. (2002). Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro. Journal of Agricultural and Food Chemistry, 50, 1725-1730.
178. Justesen, U.; Arrigoni, E.; Larsen, B. R.; and Amado, R. (2000). Degradation of flavonoid glycosides and aglycones during in vitro fermentation with human faecal flora. Lebensmittel-Wissenschaft und-Technologie, 33, 424-430.
179. Braune, A.; Gutschow, M.; Engst, W.; and Blaut, M. (2001). Degradation of quercetin and luteolin by Eubacterium ramulus. Applied and Environmental Microbiology, 67, 5558-5567.
180. Schoefer, L.; Mohan, R.; Schwiertz, A.; Braune, A.; and Blaut, M. (2003). Anaerobic degradation of flavonoids by Clostridium orbiscindens. Applied and Environmental Microbiology, 69, 5849-5854.
181. Schneider, H.; Simmering, R.; Hartmann, L.; Pforte, H.; and Blaut, M. (2000). Degradation of quercetin-3-glucoside in gnotobiotic rats associated with human intestinal bacteria. Journal of Applied Microbiology, 89, 1027-1037.
182. Schneider, H.; and Blaut, M. (2000). Anaerobic degradation of flavonoids by Eubacterium ramulus. Archives of Microbiology, 173, 71-75.
183. Hein, E. M.; Rose, K.; Van't Slot, G.; Friedrich, A. W.; and Humpf, H. U. (2008). Deconjugation and degradation of flavonol glycosides by pig cecal microbiota characterized by fluorescence in situ hybridization (FISH). Journal of Agricultural and Food Chemistry, 56, 2281-2290.
184. McGhie, T. K.; Ainge, G. D.; Barnett, L. E.; Cooney, J. M.; and Jensen, D. J. (2003). Anthocyanin Glycosides from Berry Fruit Are Absorbed and Excreted Unmetabolized by Both Humans and Rats. Journal of Agricultural and Food Chemistry, 51, 4539-4548.
185. Moon, Y. J.; and Morris, M. E. (2007). Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: Effects of quercetin and EGCG on biochanin A disposition in rats. Molecular Pharmaceutics, 4, 865-872.
186. Rechner, A. R.; Kuhnle, G.; Hu, H. L.; Roedig-Penman, A.; van den Braak, M. H.; Moore, K. P.; and Rice-Evans, C. A. (2002). The metabolism of dietary polyphenols and the relevance to circulating levels of conjugated metabolites. Free Radical Research, 36, 1229-1241.
187. Cooney, J. M.; Jensen, D. J.; and McGhie, T. K. (2004). LC-MS identification of anthocyanins in boysenberry extract and anthocyanin metabolites in human urine following dosing. Journal of the Science of Food and Agriculture, 84, 237-245.
188. Wu, X.; Pittman, H. E., III; McKay, S.; and Prior, R. L. (2005). Aglycones and sugar moieties alter anthocyanin absorption and metabolism after berry consumption in weanling pigs. Journal of Nutrition, 135, 2417-2424.
189. Wu, X.; Pittman, H. E., III; and Prior, R. L. (2004). Pelargonidin is absorbed and metabolized differently than cyanidin after marionberry consumption in pigs. Journal of Nutrition, 134, 2603-2610.
190. Baba, S.; Osakabe, N.; Natsume, M.; Muto, Y.; Takizawa, T.; and Terao, J. (2001). Absorption and urinary excretion of (-)-epicatechin after administration of different levels of cocoa powder or (-)-epicatechin in rats. Journal of Agricultural and Food Chemistry, 49, 6050-6056.
191. Roura, E.; Almajano, M. P.; Bilbao, M. L. M.; Andres-Lacueva, C.; Estruch, R.; and Lamuela-Raventos, R. M. (2007). Human urine: Epicatechin metabolites and antioxidant activity after cocoa beverage intake. Free Radical Research, 41, 943-949.
192. Roura, E.; Andres-Lacueva, C.; Estruch, R.; Mata-Bilbao, M. L.; Izquierdo-Pulido, M.; Waterhouse, A. L.; and Lamuela-Raventos, R. M. (2007). Milk does not affect the bioavailability of cocoa powder flavonoid in healthy human. Annals of Nutrition and Metabolism, 51, 493-498.
193. Valentova, K.; Stejskal, D.; Bednar, P.; Vostalova, J.; Cihalik, C.; Vecerova, R.; Koukalova, D.; Kolar, M.; Reichenbach, R.; Sknouril, L.; Ulrichova, J.; and Simanek, V. (2007). Biosafety, antioxidant status, and metabolites in urine after consumption of dried cranberry juice in healthy women: A pilot double-blind placebo-controlled trial. Journal of Agricultural and Food Chemistry, 55, 3217-3224.
194. Meng, X.; Sang, S.; Zhu, N.; Lu, H.; Sheng, S.; Lee, M. J.; Ho, C. T.; and Yang, C. S. (2002). Identification and Characterization of Methylated and Ring-Fission Metabolites of Tea Catechins Formed in Humans, Mice, and Rats. Chemical Research in Toxicology, 15, 1042-1050.
195. Netzel, M.; Strass, G.; Bitsch, R.; Dietrich, H.; Herbst, M.; Bitsch, I.; and Frank, T. (2005). The excretion and biological antioxidant activity of elderberry antioxidants in healthy humans. Food Research International, 38, 905-910.
196. Natsume, M.; Osakabe, N.; Oyama, M.; Sasaki, M.; Baba, S.; Nakamura, Y.; Osawa, T.; and Terao, J. (2003). Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: differences between human and rat. Free Radical Biology and Medicine, 34, 840-849.
197. Coldham, N. G.; Howells, L. C.; Santi, A.; Montesissa, C.; Langlais, C.; King, L. J.; Macpherson, D. D.; and Sauer, M. J. (1999). Biotransformation of genistein in the rat: elucidation of metabolite structure by product ion mass fragmentologyn. The Journal of Steroid Biochemistry and Molecular Biology, 70, 169-184.
198. Li, C.; Lee, M. J.; Sheng, S.; Meng, X.; Prabhu, S.; Winnik, B.; Huang, B.; Chung, J. Y.; Yan, S.; Ho, C. T.; and Yang, C. S. (2000). Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chemical Research in Toxicology, 13, 177-184.
199. Abd El Mohsen, M.; Marks, J.; Kuhnle, G.; Rice-Evans, C.; Moore, K.; Gibson, G.; Debnam, E.; and Srai, S. K. (2004). The differential tissue distribution of the citrus flavanone naringenin following gastric instillation. Free Radical Research, 38, 1329-1340.
200. Mennen, L. I.; Sapinho, D.; Ito, H.; Bertrais, S.; Galan, P.; Hercberg, S.; and Scalbert, A. (2007). Urinary flavonoids and phenolic acids as biomarkers of intake for polyphenol-rich foods. British Journal of Nutrition, 96, 191-198.
201. Felgines, C.; Texier, O.; Besson, C.; Fraisse, D.; Lamaison, J.-L.; and Remesy, C. (2002). Blackberry anthocyanins are slightly bioavailable in rats. Journal of Nutrition, 132, 1249-1253.
202. Milbury, P. E.; Cao, G.; Prior, R. L.; and Blumberg, J. (2002). Bioavailablility of elderberry anthocyanins. Mechanisms of Ageing and Development, 123, 997-1006.
203. Wu, X.; Cao, G.; and Prior, R. L. (2002). Absorption and metabolism of anthocyanins in elderly women after consumption of elderberry or blueberry. Journal of Nutrition, 132, 1865-1871.
204. Shoji, T.; Masumoto, S.; Moriichi, N.; Akiyama, H.; Kanda, T.; Ohtake, Y.; and Goda, Y. (2006). Apple procyanidin oligomers absorption in rats after oral administration: Analysis of procyanidins in plasma using the porter method and high-performance liquid chromatography/tandem mass spectrometry. Journal of Agricultural and Food Chemistry, 54, 884-892.
205. Gross, M.; Pfeiffer, M.; Martini, M.; Campbell, D.; Slavin, J.; and Potter, J. (1996). The quantitation of metabolites of quercetin flavonols in human urine. Cancer Epidemiology Biomarkers and Prevention, 5, 711-720.
206. Catterall, F.; King, L. J.; Clifford, M. N.; and Ioannides, C. (2003). Bioavailability of dietary doses of H-3-labelled tea antioxidants (+)-catechin and (-)-epicatechin in rat. Xenobiotica, 33, 743-753.
207. Toshiyuki, K.; Natsuki, M.; Mana, Y.; Masayuki, S.; Fumio, N.; Yukihiko, H.; and Naoto, O. (2001). Metabolic fate of (-)-[4-3H]epigallocatechin gallate in rats after oral administration. Journal of Agricultural and Food Chemistry, 49, 4102-4112.
208. Heinonen, S. M.; Wahala, K.; and Adlercreutz, H. (2004). Identification of urinary metabolites of the red clover isoflavones formononetin and biochanin A in human subjects. Journal of Agricultural and Food Chemistry, 52, 6802-6809.
209. Heinonen, S. M.; Wahala, K.; Liukkonen, K. H.; Aura, A. M.; Poutanen, K.; and Adlercreutz, H. (2004). Studies of the in vitro intestinal metabolism of isoflavones aid in the identification of their urinary metabolites. Journal of Agricultural and Food Chemistry, 52, 2640-2646.
210. Bitsch, R.; Netzel, M.; Strass, G.; Frank, T.; and Bitsch, I. (2004). Bioavailability and biokinetics of anthocyanins from red grape juice and red wine. Journal of Biomedicine and Biotechnology, 2004, 293-298.
211. Felgines, C.; Talavera, S.; Gonthier, M.-P.; Texier, O.; Scalbert, A.; Lamaison, J.-L.; and Remesy, C. (2003). Strawberry anthocyanins are recovered in urine as glucuro-and sulfoconjugates in humans. Journal of Nutrition 133, 1296-1301.
212. Mullen, W.; Edwards, C. A.; Serafini, M.; and Crozier, A. (2008). Bioavailability of pelargonidin-3-O-glucoside and its metabolites in humans following the ingestion of strawberries with and without cream. Journal of Agricultural and Food Chemistry, 56, 713-719.
213. Olthof, M. R.; Hollman, P. C. H.; Buijsman, M. N. C. P.; Amelsvoort, J. M. M. v.; and Katan, M. B. (2003). Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. The Journal of Nutrition, 133, 1806-1814.
214. Baker, M. E. (2002). Albumin, steroid hormones and the origin of vertebrates. Journal of Endocrinology, 175, 121-127.
215. Ames, B. N.; and Gold, L.S. (1997). Environmental pollution, pesticides, and the prevention of cancer: Misconceptions. Faseb Journal, 11, 1041-1052.
216. Baker, M. E. (1995). Endocrine activity of plant-derived compounds -an evolutionary perspective. Proceedings of the Society for Experimental Biology and Medicine, 208, 131-138.
217. Janisch, K. M.; Williamson, G.; Needs, P.; and Plumb, G. W. (2004). Properties of quercetin conjugates: Modulation of LDL oxidation and binding to human serum albumin. Free Radical Research, 38, 877-884.
218. Kitson, T. M. (2004). Spectrophotometric and kinetic studies on the binding of the bioflavonoid quercetin to bovine serum albumin. Bioscience Biotechnology and Biochemistry, 68, 2165-2170.
219. Papadopoulou, A.; Green, R. J.; and Frazier, R. A. (2005). Interaction of flavonoids with bovine serum albumin: A fluorescence quenching study. Journal of Agricultural and Food Chemistry, 53, 158-163.
220. Dufour, C.;and Dangles, O. (2005). Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy. Biochimica et Biophysica Acta-General Subjects, 1721, 164-173.
221. Lancon, A.; Delmas, D.; Osman, H.; Thenot, J. P.; Jannin, B.; and Latruffe, N. (2004). Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochemical and Biophysical Research Communications, 316, 1132-1137.
222. Fasano, M.; Curry, S.; Terreno, E.; Galliano, M.; Fanali, G.; Narciso, P.; Notari, S.; and Ascenzi, P. (2005). The extraordinary ligand binding properties of human serum albumin. Iubmb Life, 57, 787-796.
223. Hong, J.; Lambert, J. D.; Lee, S. H.; Sinko, P. J.; and Yang, C. S. (2003). Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)epigallocatechin-3-gallate and its methyl metabolites. Biochemical and Biophysical Research Communications, 310, 222-227.
224. Hurst, R. D.; and Fritz, I. B. (1996). Properties of an immortalised vascular endothelial glioma cell co-culture model of the blood-brain barrier. Journal of Cellular Physiology, 167, 81-88.
225. Youdim, K. A.; Dobbie, M. S.; Kuhnle, G.; Proteggente, A. R.; Abbott, N. J.; and Rice-Evans, C. (2003). Interaction between flavonoids and the blood-brain barrier: in vitro studies. Journal of Neurochemistry, 85, 180-192.
226. Abd El Mohsen, M. M.; Kuhnle, G.; Rechner, A. R.; Schroeter, H.; Rose, S.; Jenner, P.; and Rice-Evans, C. A. (2002). Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radical Biology and Medicine, 33, 1693-1702.
227. Youdim, K. A.; Qaiser, M. Z.; Begley, D. J.; Rice-Evans, C. A.; and Abbott, N. J. (2004). Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radical Biology and Medicine, 36, 592-604.
228. Koga, T.; and Meydani, M. (2001). Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. American Journal of Clinical Nutrition, 73, 941-948.
229. Gläßer, G.; Graefe, E. U.; Struck, F.; Veit, M.; and Gebhardt, R. (2002). Comparison of antioxidative capacities and inhibitory effects on cholesterol biosynthesis of quercetin and potential metabolites. Phytomedicine, 9, 33-40.
230. Shirai, M.; Moon, J. H.; Tsushida, T.; and Terao, J. (2001). Inhibitory effect of a quercetin metabolite, quercetin 3-O-beta-D-Glucuronide, on lipid peroxidation in liposomal membranes. Journal of Agricultural and Food Chemistry, 49, 5602-5608.
231. Shirai, M.; Yamanishi, R.; Moon, J. H.; Murota, K.; and Terao, J. (2002). Effect of quercetin and its conjugated metabolite on the hydrogen peroxide-induced intracellular production of reactive oxygen species in mouse fibroblasts. Bioscience Biotechnology and Biochemistry, 66, 1015-1021.
232. Yoshizumi, M.; Tsuchiya, K.; Suzaki, Y.; Kirima, K.; Kyaw, M.; Moon, J.-H.; Terao, J.; and Tamaki, T. (2002). Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochemical and Biophysical Research Communications, 293, 1458-1465.
233. O'Leary, K. A.; Pascual-Tereasa, S. d.; Needs, P. W.; Bao, Y.-P.; O'Brien, N. M.; and Williamson, G. (2004). Effect of flavonoids and Vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 551, 245-254.
234. Lodi, F.; Jimenez, R.; Menendez, C.; Needs, P. W.; Duarte, J.; and Perez-Vizcaino, F. (2008). Glucuronidated metabolites of the flavonoid quercetin do not auto-oxidise, do not generate free radicals and do not decrease nitric oxide bioavailability. Planta Medica, 74, 741-746.
235. Loke, W. M.; Proudfoot, J. M.; McKinley, A. J.; Needs, P. W.; Kroon, P. A.; Hodgson, J. M.; and Croft, K. D. (2008). Quercetin and its in vivo metabolites inhibit neutrophil-mediated low-density lipoprotein oxidation. Journal of Agricultural and Food Chemistry, 56, 3609-3615.
236. Spencer, J. P. E.; Rice-Evans, C.; and Williams, R. J. (2003). Modulation of pro-survival Akt/Protein Kinase B and ERK1/2 signaling cascades by quercetin and Its in vivo metabolites underlie their action on neuronal viability. Journal of Biological Chemistry, 278, 34783-34793.
237. Day, A.J.; Bao, Y.; Morgan, M. R. A.; and Williamson, G. (2000). Conjugation position of quercetin glucuronides and effect on biological activity. Free Radical Biology and Medicine, 29, 1234-1243.
238. Kuo, H. M.; Ho, H. J.; Chao, P. D. L.; and Chung, J. G. (2002). Quercetin glucuronides inhibited 2-aminofluorene acetylation in human acute myeloid HL-60 leukemia cells. Phytomedicine, 9, 625-631.
239. Saito, A.; Sugisawa, A.; Umegaki, K.; and Sunagawa, H. (2004). Protective Effects of Quercetin and Its Metabolites on H2O2-Induced Chromosomal Damage to WIL2-NS Cells. Bioscience, Biotechnology, and Biochemistry, 68, 271-276.
240. Liu, W.; and Liang, N. (2000). Inhibitory effect of disodium qurecetin-7, 4'-disulfate on aggregation of pig platelets induced by thrombin and its mechanism. Acta Pharmacologica Sinica, 21, 737-741.
241. Fang, S.-H.; Hou, Y.-C.; Chang, W.-C.; Hsiu, S.-L.; Lee Chao, P.-D.; and Chiang, B.-L. (2003). Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sciences, 74, 743-756.
242. Hsieh, C.-L.; Chao, P. D. L.; and Fang, S. H. (2005). Morin sulphates/glucuronides enhance macrophage function in microgravity culture system. European Journal of Clinical Investigation, 35, 591-596.
243. van Zanden, J. J.; van der Woude, H.; Vaessen, J.; Usta, M.; Wortelboer, H. M.; Cnubben, N. H. P.; and Rietjens, I. (2007). The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential. Biochemical Pharmacology, 74, 345-351.
244. Tseng, T.-H.; Wang, C.-J.; Kao, E.-S.; and Chu, h.-Y. (1996). Hibiscus protocatechuic acid protects against oxidative damage induced by tert-butylhydroperoxide in rat primary hepatocytes. Chemico-Biological Interactions, 101, 137-148.
245. Tseng, T.-H.; Kao, T.-W.; Chu, C.-Y.; Chou, F.-P.; Lin, W.-L.; and Wang, C.-J. (2000). Induction of apoptosis by Hibiscus protocatechuic acid in human leukemia cells via reduction of retinoblastoma (RB) phosphorylation and Bcl-2 expression. Biochemical Pharmacology, 60, 307-315.
246. Liu, C.-L.; Wang, J.-M.; Chu, C.-Y.; Cheng, M.-T.; and Tseng, T.-H. (2002). In vivo protective effect of protocatechuic acid on tert-butyl hydroperoxide-induced rat hepatotoxicity. Food and Chemical Toxicology, 40, 635-641.
247. Tarozzi, A.; Morroni, F.; Hrelia, S.; Angeloni, C.; Marchesi, A.; Cantelli-Forti, G.; and Hrelia, P. (2007). Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells. Neuroscience Letters, 424, 36-40.
248. Lu, H.; Meng, X.; Li, C.; Sang, S.; Patten, C.; Sheng, S.; Hong, J.; Bai, N.; Winnik, B.; Ho, C.-T.; and Yang, C. S. (2003). Glucuronides of Tea Catechins: Enzymology of Biosynthesis and Biological Activities. Drug Metabolism and Disposition, 31, 452-461.
249. Spencer, J. P. E.; Schroeter, H.; Crossthwaithe, A. J.; Kuhnle, G.; Williams, R. J.; and Rice-Evans, C. (2001). Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts. Free Radical Biology and Medicine, 31, 1139-1146.
250. Spencer, J. P. E.; Schroeter, H.; Kuhnle, G.; Srai, S. K. S.; Tyrrell, R. M.; Hahn, U.; and Rice-Evans, C. (2001). Epicatechin and its in vivo metabolite, 3 '-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation. Biochemical Journal, 354, 493-500.
251. Li, S. M.; Sang, S. M.; Pan, M. H.; Lai, C. S.; Lo, C. Y.; Yang, C. S.; and Ho, C. T. (2007). Anti-inflammatory property of the urinary metabolites of nobiletin in mouse. Bioorganic and Medicinal Chemistry Letters, 17, 5177-5181.
252. Stevenson, D.; Cooney, J.; Jensen, D.; Wibisono, R.; Adaim, A.; Skinner, M.; and Zhang, J. (2008). Comparison of enzymically glucuronidated flavonoids with flavonoid aglycones in an in vitro cellular model of oxidative stress protection. In Vitro Cellular and Developmental Biology -Animal, 44, 73-80.
253. Cano, A.; Arnao, M. B.; Williamson, G.; and Garcia-Conesa, M. T. (2002). Superoxide scavenging by polyphenols: effect of conjugation and dimerization. Redox Report, 7, 379-383.
254. Proteggente, A. R.; Basu-Modak, S.; Kuhnle, G.; Gordon, M. J.; Youdim, K.; Tyrrell, R.; and Rice-Evans, C. A. (2003). Hesperetin glucuronide, a photoprotective agent arising from Ffavonoid metabolism in human skin fibroblasts and para. Photochemistry and Photobiology, 78, 256-261.
255. Spencer, J. P. E.; Kuhnle, G. G. C.; Williams, R. J.; and Rice-Evans, C. (2003). Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochemical Journal, 372, 173-181.
256. de Pascual-Teresa, S.; Johnston, K. L.; DuPont, M. S.; O'Leary, K. A.; Needs, P. W.; Morgan, L. M.; Clifford, M. N.; Bao, Y. P.; and Williamson, G. (2004). Quercetin metabolites downregulate cyclooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo. Journal of Nutrition, 134, 552-557.
257. Paulke, A.; Noldner, M.; Schubert-Zslavecz, M.; and Wurglics, M. (2008). St. John's wort flavonolds and their metabolites show antidepressant activity and accumulate in brain after multiple oral doses. Pharmazie, 63, 296-302.
258. Hubbard, G. P.; Wolffram, S.; de Vos, R.; Bovy, A.; Gibbins, J. M.; and Lovegrove, J. A. (2006). Ingestion of onion soup high in quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in man: a pilot study. British Journal of Nutrition, 96, 482-488.
259. Kawai, Y.; Nishikawa, T.; Shiba, Y.; Saito, S.; Murota, K.; Shibata, N.; Kobayashi, M.; Kanayama, M.; Uchida, K.; and Terao, J. (2008). Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries -Implication in the anti-atherosclerotic mechanism of dietary flavonoids. Journal of Biological Chemistry, 283, 9424-9434.
260. Jackman, K. A.; Woodman, O. L.; and Sobey, C. G. (2007). Isoflavones, equol and cardiovascular disease: Pharmacological and therapeutic insights. Current Medicinal Chemistry, 14, 2824-2830.
261. Nam Joo, K.; Ki Won, L.; Rogozin, E. A.; Yong-Yeon, C.; Yong-Seok, H.; Bode, A. M.; Hyong Joo, L.; and Zigang, D. (2007). Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway. Journal of Biological Chemistry, 282, 32856-32866.
262. Zhang, Y.; Song, T. T.; Cunnick, J. E.; Murphy, P. A.; and Hendrich, S. (1999). Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. The Journal of Nutrition, 129, 399-405.
263. Niculescu, M.D.; Pop, E. A.; Fischer, L. M.; and Zeisel, S. H. (2007). Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not. Journal of Nutritional Biochemistry, 18, 380-390.
264. Rachon, D.; Seidlova-Wuttke, D.; Vortherms, T.; and Wuttke, W. (2007). Effects of dietary equol administration on ovariectomy induced bone loss in Sprague-Dawley rats. Maturitas, 58, 308-315.
265. Rachon, D.; Vortherms, T.; Seidlova-Wuttke, D.; and Wuttke, W. (2007). Effects of dietary equol on body weight gain, intra-abdominal fat accumulation, plasma lipids, and glucose tolerance in ovariectomized Sprague-Dawley rats. Menopause-the Journal of the North American Menopause Society, 14, 925-932.
266. Ohtomo, T.; Uehara, M.; Penalvo, J. L.; Adlercreutz, H.; Katsumata, S.; Suzuki, K.; Takeda, K.; Masuyama, R.; and Ishimi, Y. (2008). Comparative activities of daidzein metabolites, equol and O-desmethylangolensin, on bone mineral density and lipid metabolism in ovariectomized mice and in osteoclast cell cultures. European Journal of Nutrition, 47, 273-279.
267. Rachon, D.; Menche, A.; Vortherms, T.; Seidlova-Wuttke, D.; and Wuttke, W. (2008). Effects of dietary equol administration on the mammary gland in ovariectomized Sprague-Dawley rats. Menopause-the Journal of the North American Menopause Society, 15, 340-345.
268. Rechner, A. R.; and Kroner, C. (2005). Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function. Thrombosis Research, 116, 327-334.
269. Hiermann, A.; Schramm, H. W.; and Laufer, S. (1998). Anti-inflammatory activity of myricetin-3-O-beta-D-glucuronide and related compounds. Inflammation Research, 47, 421-427.
270. Guo, J. M.; Qian, F.; Li, J. X.; Xu, Q.; and Chen, T. (2007). Identification of a new metabolite of astilbin, 3 '-O-methylastilbin, and its immunosuppressive activity against contact dermatitis. Clinical Chemistry, 53, 465-471.
271. Bellion, P.; Hofmann, T.; Pool-Zobel, B. L.; Will, F.; Dietrich, H.; Knaup, B.; Richling, E.; Baum, M.; Eisenbrand, G.; and Janzowski, C. (2008). Antioxidant effectiveness of phenolic apple juice extracts and their gut fermentation products in the human colon carcinoma cell line caco-2. Journal of Agricultural and Food Chemistry, 56, 63106317.
272. Chan, F. L.; Choi, H. L.; Chen, Z. Y.; Chan, P. S. F.; and Huang, Y. (2000). Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin. Cancer Letters, 160, 219-228.
273. Ueda, S.; Nakamura, H.; Masutani, H.; Sasada, T.; Takabayashi, A.; Yamaoka, Y.; and Yodoi, J. (2002). Baicalin induces apoptosis via mitochondrial pathway as prooxidant. Molecular Immunology, 38, 781-791.
274. Canali, R.; Ambra, R.; Stelitano, C.; Mattivi, F.; Scaccini, C.; and Virgili, F. (2007). A novel model to study the biological effects of red wine at the molecular level. British Journal of Nutrition, 97, 1053-1058.
275. Shukla, M.; Gupta, K.; Rasheed, Z.; Khan, K.; and Haqqi, T. (2008). Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro. Journal of Inflammation, 5, 9.